SCHEMBL7778742

SCHEMBL7778742

OCC(NCCOc1ccc2c(c1)[nH]c1ccccc12)c1ccc(O)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSV O60911 1/20 0.42
CTSL P07711 1/20 0.42
KIF11 P52732 5/20 0.39
CYP19A1 P11511 1/20 0.38
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
DRD4 P21917 2/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAOA P21397 1/20 0.35
NR1I2 O75469 1/20 0.35
ROCK2 O75116 1/20 0.35
ADRB2 P07550 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7781279 0.88 KIF11 (0.39) CTSVCTSLKIF11THRBHTT
SCHEMBL7781344 0.85 ADRB2 (0.40) CTSVCTSLKIF11CYP19A1THRB
SCHEMBL7778756 0.84 CTSV (0.38) CTSVCTSLKIF11THRBHTT
SCHEMBL7778926 0.82 KIF11 (0.41) CTSVCTSLKIF11THRBHTT
SCHEMBL7779190 0.81 CTSV (0.45) CTSVCTSLGABRA1GABRG2GABRB3
SCHEMBL6914729 0.80 ALOX15 (0.46) CTSVCTSLDRD4DRD2DRD3
SCHEMBL7782053 0.80 CTSV (0.43) CTSVCTSLCYP19A1HTTDRD4
Hydrochloric Acid SCHEMBL7116547 0.80 ALOX15 (0.47) CTSVCTSLDRD4DRD2DRD3
SCHEMBL12886607 0.74 MAOA (0.57) CTSVCTSLKIF11THRBHTT
SCHEMBL16792082 0.74 ADRB2 (0.53) CTSVCTSLKIF11GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1128845-A1 COMBINATIONS COMPRISING A BETA-AGONIST AND A FURTHER ANTDIABETIC AGENT SMITHKLINE BEECHAM PLC (GB) 2001-09-05 EP disclosed
WO-2000027434-A1 COMBINATIONS COMPRISING A BETA-AGONIST AND A FURTHER ANTIDIABETIC AGENT SMITHKLINE BEECHAM P.L.C. (GB) 2000-05-18 WO disclosed